Latest news RSS subscribe >

RB&HH Specialist Care consultants attending ESC Congress 2017

Saturday 26 – Wednesday 30 August 2017 Barcelona – Spain Spotlight 2017: 40 Years of PCI The world’s largest cardiovascular congress with over 500 experts sessions and more than 4 500 abstracts…

New hope for patients with life-limiting heart disease

With more than a million over-65 year olds thought to be affected by heart valve disease in the UK alone, experts at RB&HH have been leading the way in recent years to develop new lifesaving alternatives for patients…

Our new Hypertrophic Cardiomyopathy service

Hypertrophic Cardiomyopathy is the commonest inherited cardiac condition and associated with an increased risk of sudden death in the young. It is frequently associated with symptomatic Left Ventricular Outflow Tract…

Introducing our recently accredited Genetics and Genomics Laboratory

Based at the Royal Brompton Hospital the Clinical Genetics and Genomics laboratory offers diagnostic testing for families and individuals at risk of inherited diseases. The team of clinical experts assess whether…

First patients benefit from pioneering treatment for aortic valve disease

RB&HH experts hope new Ozaki procedure could revolutionise the way surgery is carried out in the UK for patients with the life-threatening condition. As one of the country’s largest and…

The Power of Echocardiography

“Echocardiography can show how the heart is managing the blood flow in different dynamic conditions, such as during and after exercise; revealing abnormalities that are not easy to detect when…

3D Imaging and Printing: Technology of the future at the Trust

Specialists are using 3D imaging and printing to create exact replicas of patients’ hearts to help them plan and carry out surgery. The technique requires specialist cardiovascular magnetic resonance (CMR)…

Treatment for ‘sudden death syndrome’ performed at Arab Health

A life-changing surgical myectomy for the management of Obstructive Hypertrophic Cardiomyopathy was performed by our leading consultants – Mr Fabio De Robertis and Dr Antonis Pantazis this week at Arab Health 2017. The…

RB&HH to showcase new Hypertrophic Cardiomyopathy diagnostic and management service at Arab Health 2017

In January, RB&HH Specialist Care are set to attend Arab Health 2017, the largest healthcare exhibition and medical congress in the Middle East. During the event, Mr Fabio De Robertis…

An innovative therapy to restore Pulmonary Valve Function

Congenital heart disease (CHD) is the most commonly observed birth defect and a leading cause of infant death in the developed world. Royal Brompton Hospital is pioneering an alternative treatment…